Caveolin-1 expression in advanced-stage ovarian carcinoma - A clinicopathologic study

Gynecologic Oncology

Volumn 81, Issue 2, 2001, Pages 166-171

  Davidson, Ben ^a   Nesland, Jahn M ^a   Goldberg, Iris ^b   Kopolovic, Juri ^b   Gotlieb, Walter H ^c   Bryne, Magne ^b   Ben Baruch, Gilad ^c   Berner, Aasmund ^a   Reich, Reuven ^a,d  

^a UNIVERSITY OF OSLO   (Norway)

^b SHEBA MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

^d HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Caveolin 1; Disease outcome; Immunohistochemistry; Ovarian carcinoma

Indexed keywords

ANTINEOPLASTIC AGENT; CAVEOLIN 1; CISPLATIN; CYCLOPHOSPHAMIDE; PACLITAXEL;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; FEMALE; GYNECOLOGIC CANCER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MULTIMODALITY CANCER THERAPY; OVARY CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TREATMENT OUTCOME; TUMOR SUPPRESSOR GENE;

EID: 0035011210     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.2001.6156     Document Type: Article

References (30)

1. Caveolin, a protein component of caveolae membrane coats
2. Caveolae: Where incoming and outgoing messengers meet
3. Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane
4. Protein complexes '98. Moleculer genetics of the caveolin gene family: Implications for human cancers, diabetes, Alzheimer disease, and molecular dystrophy
5. Genes encoding human caveolin-1 and -2 are co-localized to the D7S522 locus (7q31.1), a known fragile site (FRA7G) that is frequently deleted in human cancers
6. Sequence and detailed organization of the human caveolin-1 and -2 genes located near the D7S522 locus (7q31.1). Methylation of a CpG island in the 5′ promoter region of the caveolin-1 gene in human breast cancer cell lines
7. Reduction of caveolin 1 gene expression in lung carcinoma cell lines
8. Interaction of a receptor tyrosine kinase, EGF-R, with caveolins. Caveolin binding negatively regulates tyrosine and serine/threonine kinase activities
9. Caveolin is an inhibitor of platelet-derived growth factor receptor signaling
10. Reciprocal regulation of Neu tyrosine kinase activity and caveolin-1 protein expression in vitro and in vivo. Implications for human breast cancer
11. Recombinant expression of caveolin-1 in oncogenically transformed cells abrogates anchorage-dependent growth
12. Tumor cell growth inhibition by caveolin re-expression in human breast cancer cells
13. Analysis of caveolin-1 gene at human chromosome 7q31.1 in primary tumours and tumour-derived cell lines
14. Elevated expression of caveolin is associated with prostate and breast cancer
15. Caveolin-1 expression in clinically confined human prostate cancer: A novel prognostic marker
16. Global cancer statistics
17. FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: An analysis of 1973-1987 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina
18. Expression of carbohydrate antigens in advanced-stage ovarian carcinomas and their metastases - A clinicopathologic study
19. High levels of MMP-2, MMP-9, MTl-MMP and TIMP-2 mRNA correlate with poor survival in ovarian carcinoma
20. Ets-1 mRNA expression is a novel marker of poor survival in ovarian carcinoma
21. E-cadherin complex protein expression and survival in ovarian carcinoma
22. Surface epithelial-stromal tumors
23. A role for caveolin and the urokinase receptor in integrin-mediated adhesion and signaling
24. E-cadherin and α-, β- and γ-catenin protein expression is up-regulated in ovarian carcinoma cells in serous effusions
25. Biochemical and clinical implications of the ErbB/HER signaling network of growth factor receptors
26. Vascular endothelial growth factor expression in earlystage ovarian carcinomas
27. P-glycoprotein in adult solid tumors. Expression and prognostic significance
28. Up-regulation of caveolae and caveolar constituents in multidrug-resistant cancer cells
29. Upregulation of caveolin-1 and caveolae organelles in Taxol-resistant A549 cells